Is there a role for preparatory cycle in ovum donation recipients?

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 3, 2006, Pages 333-337

  Jun, Sunny H ^a   Hornstein, Mark D ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Assisted reproduction; In vitro fertilization; Oocyte donation; Preparatory cycle

Indexed keywords

ESTRADIOL VALERATE; PROGESTERONE;

ABSENCE OF SIDE EFFECTS; CORPUS LUTEUM; DRUG DOSE REGIMEN; EMBRYO TRANSFER; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; LUTEAL PHASE; MEDICAL LITERATURE; MENSTRUAL CYCLE; NIDATION; OOCYTE DONATION; PATIENT COMPLIANCE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCREENING TEST; TRANSVAGINAL ECHOGRAPHY;

ENDOMETRIUM; ESTRADIOL; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MENSTRUAL CYCLE; OOCYTE DONATION; PREMEDICATION; PROGESTINS; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 33745002929     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000193017.03900.ea     Document Type: Review

References (57)

1. Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril 1987; 47:895-909.
2. Sauer MV, Paulson RJ. Human oocyte and preembryo donation: an evolving method for the treatment of infertility. Am J Obstet Gynecol 1990; 163:1421-1424.
3. Navot D, Laufer N, Kopolovic J, et al. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 1986; 314:806-811.
4. Lelaidier C, De Ziegler D, Gaetano J, et al. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist. Hum Reprod 1992; 7:1353-1356.
5. Younis JS, Mordel N, Lewin A, et al. Artificial endometrial preparation for oocyte donation: the effect of estrogen stimulation on clinical outcome. J Assist Reprod Genet 1992; 9:222-227.
6. Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril 1996; 66:873-884.
7. Ben-Nun I, Shulman A. Induction of artificial endometrial cycles with s.c. oestrogen implants and injectable progesterone in in-vitro fertilization treatment with donated oocytes: a preliminary report. Hum Reprod 1997; 12:2267-2270.
8. Dmowski WP, Miohalowska J, Rana N, et al. Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. J Assist Reprod Genet 1997; 14:139-144.
9. Abu-Musa A, Hannoun A, Khalil A, et al. Artificial endometrial preparation for oocyte donation using synthetic estrogen and progestogen. Clin Exp Obstet Gynecol 1998; 25:83-85.
10. Lewin A, Pisov G, Turgeman R, et al. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study. Gynecol Endocrinol 2002; 16:131-136.
11. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
12. Coutifaris C, Myers ER, Guzick DS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004; 82:1264-1272.
13. Zaidi J, Campbell S, Pittrof R, Tan SL. Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an in-vitro fertilization program. Ultrasound Obstet Gynecol 1995; 1:191-198.
14. Steer CV, Campbell S, Tan SL, et al. The use of transvaginal color flow imaging after in-vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992; 57:372-376.
15. Favre R, Bettahar K, Grange G, et al. Predictive value of transvaginal uterine Doppler assessment in an in-vitro fertilization program. Ultrasound Obstet Gynecol 1993; 3:350-353.
16. Gill RW. Accuracy calculations for ultrasonic pulsed Doppler blood flow measurements. Aust Phys Eng Sci Med 1982; 5:51-57.
17. Psychoyos A. Hormonal control of ovoimplantation. Vitam Horm 1973; 31:201-256.
18. Hecht BR, Bardawil WA, Khan-Dawood FS, Dawood MY. Luteal insufficiency: correlation between endometrial dating and integrated progesterone output in clomiphene citrate-induced cycles. Am J Obstet Gynecol 1990; 163:1986-1991.
19. Davis OK, Berkeley AS, Naus GJ, et al. The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies. Fertil Steril 1989; 51:582-586.
20. Li TC, Dockery P, Rogers AW, Cooke ID. A quantitative study of endometrial development in the luteal phase: comparison between women with unexplained infertility and normal fertility. Br J Obstet Gynaecol 1990; 97:576-582.
21. Castelbaum AJ, Wheeler J, Coutifaris CB, et al. Timing of the endometrial biopsy may be critical for the accurate diagnosis of luteal phase deficiency. Fertil Steril 2000; 73:788-798.
22. Sterzik K, Abt M, Grab D, et al. Predicting the histologic dating of an endometrial biopsy specimen with the use of Doppler ultrasonography and hormone measurements in patients undergoing spontaneous ovulatory cycles. Fertil Steril 2000; 73:94-98.
23. Friedler S, Shenker JG, Herman A, Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update 1996; 2:323-335.
24. Tekay A, Martikainen H, Jouppila P. The clinical value of transvaginal colour Doppler ultrasound in assisted reproductive technology procedures. Hum Reprod 1996; 11:1589-1591.
25. Smith B, Porter R, Ahuja K, Craft I. Ultrasonic assessment of endometrial changes in stimulated cycles and in an in-vitro fertilization and embryo transfer program. J In Vitro Fert Embryo Transf 1984; 1:233-238.
26. Glissant A, De Mouzon J, Frydman R. Ultrasound study of the endometrium during in-vitro fertilization cycles. Fertil Steril 1985; 44:786-790.
27. Gonen Y, Casper RF, Jacobsen W, Blankier J. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in invitro fertilization. Fertil Steril 1989; 52:446-450.
28. Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in-vitro fertilization (IVF). J In Vitro Fert Embryo Transf 1990; 7:146-152.
29. Bustillo M, Krysa LW, Coulam CB. Uterine receptivity in an oocyte donation programme. Hum Reprod 1995; 10:442-445.
30. Shapiro H, Cowell C, Casper RF. The use of vaginal ultrasound for monitoring endometrial preparation in a donor oocyte program. Fertil Steril 1993; 59:1055-1058.
31. Dickey RP, Olar TT, Curole DN, et al. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod 1992; 7:418-421.
32. Check JH, Nowroozi K, Choe J, Dietterich C. Influence of endometrial thickness and echo patterns on pregnancy rates during in-vitro fertilization. Fertil Steril 1991; 56:1173-1175.
33. Check JH, Lurie D, Dietterich C, et al. Adverse effect of a homogeneous hyperechogenic endometrial thickness on pregnancy rates following in-vitro fertilization. Hum Reprod 1993; 8:1293-1296.
34. Oliveira JA, Baruffi RR, Mauri AL, et al. Endometrial ultrasonography as a predictor of pregnancy in an in-vitro fertilization programme. Hum Reprod 1993; 8:1312-1315.
35. Khalifa E, Brzyski RG, Oehinger S, et al. Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles. Hum Reprod 1992; 7:677-680.
36. Check JH, Nowroozi K, Choe J, et al. The effect of endometrial thickness and echo pattern on in-vitro fertilization outcome in donor oocyte-embryo transfer cycle. Fertil Steril 1993; 59:72-75.
37. Doherty CM, Silver B, Binor A, et al. Transvaginal ultrasonography and the assessment of luteal phase endometrium. Am J Obstet Gynecol 1993; 168:1702-1707.
38. Steer CV, Tan SL, Dillon D, et al. Vaginal color Doppler assessment of uterine artery impedance correlates with immunohistochemical markers of endometrial receptivity required for the implantation of an embryo. Fertil Steril 1995; 63:101-108.
39. Tekay A, Martikainen H, Jouppila P. Blood flow changes in uterine and ovarian vasculature, and predictive value of transvaginal pulsed colour Doppler ultrasonography in an in-vitro fertilization programme. Hum Reprod 1995; 10:688-693.
40. Tekay A, Martikainen H, Jouppila P. Comparison of uterine blood flow characteristics between spontaneous and stimulated cycles before embryo transfer. Hum Reprod 1996; 11:364-368.
41. Aytoz A, Ubaldi F, Tournaye H, et al. The predictive value of uterine artery blood flow measurements for uterine receptivity in an intracytoplasmic sperm injection program. Fertil Steril 1997; 68:935-937.
42. Salle B, Bied-Damon V, Benchaib M, et al. Preliminary report of an ultrasonography and colour Doppler uterine score to predict uterine receptivity in an in-vitro fertilization programme. Hum Reprod 1998; 13:1669-1673.
43. Carson DD, Lagow E, Thathiah A, et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod 2002; 8:971-979.
44. Kao LC, Tulac S, Lobo S, et al. Global gene profiling in human endometrium during the window implantation. Endocrinology 2002; 143:2119-2138.
45. Borthwick JM, Charnock-Jones DS, Tom BD, et al. Determination of the transcript profile of human endometrium. Mol Hum Reprod 2003; 9:19-33.
46. Riesewijk A, Martin J, Van Os R, et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 2003; 9:253-264.
47. Lutjen P, Trounson A, Leeton J, et al. The establishment and maintenance of pregnancy using in-vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984; 307:174-175.
48. Csemiczky G, Wramsby H, Johannisson E, Landgren BM. Clinical assisted reproduction: endometrial evaluation is not predictive for in-vitro fertilization treatment. J Assist Reprod Genet 1999; 16:113-116.
49. Devroey P, Pados G. Preparation of endometrium for egg donation. Hum Reprod Update 1998; 4:856-861.
50. Bourgain C, Devroey P, Van Waesberghe L, et al. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 1990; 5:537-543.
51. Pados G, Devroey P. Luteal phase support. Assist Reprod Rev 1992; 3:148-153.
52. De Ziegler D, Ferriani R, Moraes LA, Bulletti C. Vaginal progesterone in menopause: crinone 4% in cyclical and constant combined regimens. Hum Reprod 2000; 15:149-158.
53. Cicinelli E, De Ziegler D, Alfonso R, et al. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study. Fertil Steril 2005; 83:1859-1863. A study describing different doses and routes of estrogen and progesterone administration.
54. Potter DA, Witz CA, Burns WN, et al. Endometrial biopsy during hormone replacement cycle in donor oocyte recipients before in-vitro fertilization embryo transfer. Fertil Steril 1998; 70:219-221.
55. Jun SH, Racowsky C, Fox JH, Hornstein MD. The role of preparatory cycles in ovum donation recipients: a retrospective study. J Assist Reprod Genet 2004; 21:377-379.
56. Sauer MV, Paulson RJ, Moyer DL. Assessing the importance of endometrial biopsy prior to oocyte donation. J Assist Reprod Genet 1997; 14:125-127.
57. Scott RT, Snyder RR, Strickland DM, et al. The effect of interobserver variation in dating endometrial histology on the diagnosis of luteal phase defects. Fertil Steril 1988; 50:888-892.